EE447 Budget Impact Analysis of Tepotinib in England for Patients With Advanced Non-Small Cell Lung Cancer (aNSCLC) Harboring MET Exon 14 (METex14) Skipping
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.692
https://www.valueinhealthjournal.com/article/S1098-3015(22)02896-0/fulltext
Section Title :
Section Order :
10231
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02896-0&doi=10.1016/j.jval.2022.09.692